Active, Not Recruiting
A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years
NCT06335849
- Conditions
- Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
- Locations
-
- Nucleus Network Pty Ltd Melbourne, Victoria, Australia